Asialoscinti injection, manufactured by Nippon MediPhysics, contains Galactosyl human serum albumin diethylenetriaminepentaacetate technetium (99mTc) and is an injectable drug with a YJ code of 4300435A1020 and standard 10MBq. This radiopharmaceutical is likely used for liver function assessment, specifically targeting asialoglycoprotein receptors in hepatocytes.
Asialoscinti injection
Need more detailed information?
Contact TASAKI PHARMA for product sourcing, availability, or related support (English support available).